Ann-Kathrin Mehnert

💬 Join us for a CRC Crosstalk Seminar 💬

“Colorectal cancer heterogeneity – the dark side of plasticity”
by Helmuth Gehart, from @ethz.ch

📅 Tuesday, March 24, 2026
🕙 12:00 pm
📍 Lecture Hall, Georg-Speyer-Haus Frankfurt / Hybrid event

#TRR417 #CRCcrosstalk #TogetherAgainstColonCancer #ColonCancer

📢 Call for Abstracts - Frankfurt Cancer Conference 2026

Present your research September 2-4 as a poster or get selected for a short talk. Share your work, get feedback, and connect at the international #FrankfurtCancerConference.

📆 Deadline: March 26, 2026
🔗 www.frankfurtcancerconference.org

🆕Neue🪐Impulse aus der LOEWE-Forschung: Die🗞️ProLOEWE-NEWS 1. 2026 ist da! #Krebsforschung @loewe-fci.bsky.social, #Zukunftsmedizin, #mentaleGesundheit + ein Blick👀hinter die🎭Kulissen wissenschaftl. Karrieren diesmal Prof. Andreas Gattinger @jlugiessen.bsky.social ➡️ www.linkedin.com/posts/proloe...

𝗘𝗶𝗻𝗲𝗻 𝗧𝗮𝗴 𝗮𝗹𝘀👦🏻👧𝗡𝗮𝗰𝗵𝘄𝘂𝗰𝗵𝘀𝘄𝗶𝘀𝘀𝗲𝗻𝘀𝗰𝗵𝗮𝗳𝘁𝗹𝗲𝗿:𝗶𝗻🧪– 𝗱𝗮𝘀 𝗵𝗮𝗯𝗲𝗻 𝗟𝗢𝗘𝗪𝗘-𝗔𝗖𝗟𝗙-𝗜&𝗣𝗿𝗼𝗟𝗢𝗘𝗪𝗘 𝗵𝗲𝘂𝘁𝗲 𝗦𝗰𝗵𝘂̈𝗹𝗲𝗿:𝗶𝗻𝗻𝗲𝗻 𝗶𝗺 𝗔𝗹𝘁𝗲𝗿 𝘃𝗼𝗻 𝟴-𝟭𝟭 𝗝𝗮𝗵𝗿𝗲𝗻 𝗮𝗺 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝗮̈𝘁𝘀𝗸𝗹𝗶𝗻𝗶𝗸𝘂𝗺 𝗙𝗿𝗮𝗻𝗸𝗳𝘂𝗿𝘁 𝗮𝗺 𝗠𝗮𝗶𝗻 𝗲𝗿𝗺𝗼̈𝗴𝗹𝗶𝗰𝗵𝘁! Ein herzliches🫶🏼Danke an alle Beteiligten, die diesen besonderen Tag möglich gemacht haben➡️ www.linkedin.com/feed/update/...

📣 Registration and Abstract Submission Open:

FRANKFURT CANCER CONFERENCE 2026

Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies

🕗 September 2–4, 2026
📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE

➡️ frankfurtcancerconference.org

#FrankfurtCancerConference

Today is #WorldCancerDay!🎗️

Colorectal cancer is among the most common cancers worldwide. At SFB/TRR 417, we study the tumor microenvironment to improve CRC treatment.

👉 Visit LinkedIn for personal insights from our consortium!

#TogetherAgainstColonCancer #UnitedByUnique

worldcancerday.org

Save the Date:

FRANKFURT CANCER CONFERENCE 2026

Translating Paul Ehrlich’s Magic Bullet into Novel Targeted Therapies

🕗 Wed., September 2, 2026 – Fri., September 4, 2026

📍Campus Westend, @goetheuni.bsky.social, Frankfurt/Main, DE

➡️ www.frankfurtcancerconference.org
#frankfurtcancerconference

🚀 Strong start for our SFB/TRR 417, funded by @dfg.de! Our researchers from @goetheuni.bsky.social, @fau.de, @uni-freiburg.de, @pei.de and Georg-Speyer-Haus gathered to connect and exchange ideas on #ColorectalCancer and the #TumorMicroenvironment. Living up to our motto: #TogetherAgainstColonCancer

Great news: The #LOEWE Center Frankfurt Cancer Institute @goetheuni.bsky.social will continue to receive funding from the state of Hesse! 🎉
12 mio € for two more years – a strong signal for the importance of #translational #cancer #research in Frankfurt.
Thank you Hesse and everyone involved!!

Im @loewe-fci.bsky.social arbeiten Forschende gemeinsam an translationaler #Krebsforschung. Nun wird das #FCI weiter vom Land Hessen gefördert: Wissenschaftsminister Timon Gremmels hat heute einen Förderbescheid für die Jahre 2026/27 überreicht.

🔗 Mehr: aktuelles.uni-frankfurt.de/allgemein/12...

The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistent replication in cell culture Author summary Hepatitis E virus (HEV) is an important yet often underestimated pathogen. Depending on the genotype, HEV infections can progress to chronicity, but the underlying mechanisms remain poo...

🎉 Exciting news: my PhD project @daothilab.bsky.social has been published in #PLoS Pathogens! I investigated how the #hepatitis E virus ORF2 protein counteracts antiviral responses, contributing to persistent viral replication. A huge thank you to all collaborators! 🙏🏻
🔗 share.google/WwIT43Su3KOP...